Skip to main content
SpringerLink
Log in

Acute apixaban treatment of heparin-induced thrombocytopenia

  • Letter to the Editor
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Skelley JW, Kyle JA, Roberts RA (2016) Novel oral anticoagulants for heparin-induced thrombocytopenia. J Thromb Thrombolysis 42(2):172–178. doi:10.1007/s11239-016-1365-0

    Article  CAS  PubMed  Google Scholar 

  2. Sharifi M, Freeman W, Bay C, Sharifi M, Breed C, Schwartz F (2014) Treatment of heparin-induced thrombocytopenia with new oral anticoagulants [abstract]. J Am Coll Cardiol 63(12):A2096

    Article  Google Scholar 

  3. Sharifi M, Bay C, Vajo Z, Freeman W, Sharifi M, Schwartz F (2015) New oral anticoagulants in the treatment of heparin-induced thrombocytopenia. Thromb Res 135(4):607–609. doi:10.1016/j.thromres.2015.01.009

    Article  CAS  PubMed  Google Scholar 

  4. Larsen PB, Jørgensen M, Friis-Hansen L, Ingeberg S (2015) Apixaban used for the management of heparin-induced thrombocytopenia in a 72-year-old woman with lung cancer. Clin Case Rep 3(12):987–989. doi:10.1002/ccr3.411.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Ibarra-Sifuentes HR, Delgado-García G, Monreal-Robles R, Gallegos D, Colunga-Pedraza PR, Marfil-Rivera J (2014) Apixaban as a therapeutic option in heparin-induced thrombocytopenia in a patient on hemodialysis (PS 0323) (abstract). Korean J Intern Med 29(5 Suppl 1):S132.

    Google Scholar 

  6. Delgado-García G, Monreal-Robles R, Gallegos-Arguijo D, Marfil-Rivera J (2015) Apixaban como opción terapéutica en el paciente nefrópata con trombocitopenia inducida por heparina (TIH). Gac Med Mex 151(6):798–801

    PubMed  Google Scholar 

  7. No authors listed (2016) Heparin-induced thrombocytopenia: case report. Reactions Weekly 1590(1):107. doi:10.1007/s40278-016-15159-3.

  8. Delgado-García G, Monreal-Robles R, Gallegos-Arguijo D, Marfil-Rivera J (2015) Apixaban as a therapeutic option in chronic kidney disease patients with heparin-induced thrombocytopenia (HIT). Gac Med Mex 151(6):798–801

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University Hospital, Autonomous University of Nuevo León, Monterrey, Mexico

    Guillermo Delgado-García & Roberto Monreal-Robles

Authors
  1. Guillermo Delgado-García
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roberto Monreal-Robles
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guillermo Delgado-García.

Ethics declarations

Conflict of interest

The authors (G. D.-G., R. M.-R.) declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from the patient described in this report.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Delgado-García, G., Monreal-Robles, R. Acute apixaban treatment of heparin-induced thrombocytopenia. J Thromb Thrombolysis 43, 289–290 (2017). https://doi.org/10.1007/s11239-016-1458-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-016-1458-9

Keywords

Search

Navigation